National Health Investors Stock Price To Earning
| NHI Stock | USD 76.91 0.58 0.75% |
National Health Investors fundamentals help investors to digest information that contributes to National Health's financial success or failures. It also enables traders to predict the movement of National Stock. The fundamental analysis module provides a way to measure National Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to National Health stock.
National | Price To Earning |
National Health Investors Company Price To Earning Analysis
National Health's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current National Health Price To Earning | 13.23 X |
Most of National Health's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, National Health Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
National Price To Earning Driver Correlations
Understanding the fundamental principles of building solid financial models for National Health is extremely important. It helps to project a fair market value of National Stock properly, considering its historical fundamentals such as Price To Earning. Since National Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of National Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of National Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
National Retained Earnings
Retained Earnings |
|
Based on the latest financial disclosure, National Health Investors has a Price To Earning of 13.23 times. This is 65.28% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The price to earning for all United States stocks is 53.93% higher than that of the company.
National Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses National Health's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of National Health could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics of similar companies.National Health is currently under evaluation in price to earning category among its peers.
National Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of National Health from analyzing National Health's financial statements. These drivers represent accounts that assess National Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of National Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.5B | 3.1B | 2.6B | 2.3B | 2.4B | 2.5B | |
| Enterprise Value | 5.0B | 4.6B | 3.8B | 3.5B | 3.5B | 3.7B |
National Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, National Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to National Health's managers, analysts, and investors.Environmental | Governance | Social |
National Fundamentals
| Return On Equity | 0.0993 | ||||
| Return On Asset | 0.047 | ||||
| Profit Margin | 0.38 % | ||||
| Operating Margin | 0.63 % | ||||
| Current Valuation | 4.61 B | ||||
| Shares Outstanding | 45.42 M | ||||
| Shares Owned By Insiders | 4.67 % | ||||
| Shares Owned By Institutions | 68.20 % | ||||
| Number Of Shares Shorted | 1.45 M | ||||
| Price To Earning | 13.23 X | ||||
| Price To Book | 2.86 X | ||||
| Price To Sales | 10.59 X | ||||
| Revenue | 319.83 M | ||||
| Gross Profit | 268.98 M | ||||
| EBITDA | 251.49 M | ||||
| Net Income | 134.38 M | ||||
| Cash And Equivalents | 19.29 M | ||||
| Cash Per Share | 0.97 X | ||||
| Total Debt | 1.14 B | ||||
| Debt To Equity | 0.78 % | ||||
| Current Ratio | 2.78 X | ||||
| Book Value Per Share | 33.73 X | ||||
| Cash Flow From Operations | 184.45 M | ||||
| Short Ratio | 5.19 X | ||||
| Earnings Per Share | 2.91 X | ||||
| Price To Earnings To Growth | 1.99 X | ||||
| Target Price | 85.0 | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 3.49 B | ||||
| Total Asset | 2.49 B | ||||
| Retained Earnings | 2.47 B | ||||
| Working Capital | 285.14 M | ||||
| Current Asset | 73.06 M | ||||
| Current Liabilities | 52.78 M | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 6.01 % | ||||
| Net Asset | 2.49 B | ||||
| Last Dividend Paid | 3.6 |
About National Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze National Health Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of National Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of National Health Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out National Health Piotroski F Score and National Health Altman Z Score analysis. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.